首页 | 本学科首页   官方微博 | 高级检索  
     

来氟米特治疗强直性脊柱炎伴周围关节炎
引用本文:李东旭,帅宗文,陈珊宇,徐胜前,徐舟舟,徐建华. 来氟米特治疗强直性脊柱炎伴周围关节炎[J]. 安徽医科大学学报, 2011, 46(10): 1056-1060
作者姓名:李东旭  帅宗文  陈珊宇  徐胜前  徐舟舟  徐建华
作者单位:安徽医科大学第一附属医院风湿免疫科,合肥,230022
摘    要:目的 探讨来氟米特(LFM)治疗难治性强直性脊柱炎(AS)伴周围关节炎的疗效和安全性.方法 采用患者单盲、随机及安慰剂对照的临床试验研究方法,将67例经柳氮磺胺吡啶(SSZ)和非甾体抗炎药(NSAIDs)治疗无效的活动性AS伴周围关节炎患者随机分为两组,分别接受LFM和安慰剂治疗,疗程24周,观察疗效和不良反应.结果 ...

关 键 词:来氟米特  强直性脊柱炎  临床试验  不良反应

A clinical study on leflunomide in the treatment of refractory ankylosing spondylitis with peripheral arthritis
Li Dongxu,Shuai Zongwen,Chen Shanyu,et al. A clinical study on leflunomide in the treatment of refractory ankylosing spondylitis with peripheral arthritis[J]. Acta Universitis Medicinalis Anhui, 2011, 46(10): 1056-1060
Authors:Li Dongxu  Shuai Zongwen  Chen Shanyu  et al
Affiliation:Li Dongxu,Shuai Zongwen,Chen Shanyu,et al (Dept of Rheumatology and Immunology,The First Affiliated Hospital of Anhui Medical University,Hefei 230022)
Abstract:Objective To evaluate the efficacy and safety of leflunomide(LFM) in the treatment of refractory ankylosing spondylitis(AS) with peripheral arthritis.Methods A patient-blind,randomized,placebo-controlled clinical trial was employed in this study.67 cases of active AS with peripheral arthritis patients,who were refractory to the therapy of sulfasalazine(SSZ) and non-steroidal anti-inflammatory drugs(NSAIDs),were randomized at baseline to receive either LFM or matching placebo for 24 weeks.The therapeutic eff...
Keywords:leflunomide  ankylosing spondylitis  clinical trials  adverse reaction  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号